(RTTNews) - Immuron (IMRN) announced the FDA has approved Investigational New Drug application for IMM-529 and the Phase 2 clinical trial may proceed. The company plans to initiate a Phase 2 clinical ...

Company takes next step in planned uplisting from OTC Markets MIAMI, FL / ACCESS Newswire / November 24, 2025 / Luminar Media Group, Inc. (OTCID:LRGR) ("Luminar" or the "Company"), a diversified ...

Robotics companies are at the forefront of innovation, driving efficiency and productivity across industries such as manufacturing, healthcare and logistics. The global robotics market is poised for ...

- BLA for veligrotug successfully submitted to the U.S. Food and Drug Administration (FDA) in late October following recent consultation with the agency - - Veligrotug’s Breakthrough Therapy ...

LAS VEGAS--(BUSINESS WIRE)-- CONNECTIONS CONFERENCE -- Guidewire (NYSE: GWRE) today introduced PricingCenter, enabling P&C insurers to deliver pricing changes quickly and with greater precision – ...

Achieve Life Sciences Inc. (NASDAQ:ACHV) is one of the Canadian penny stocks to buy right now. Lake Street’s Thomas Flaten ...

Fuxing China Group first announced that it was looking to explore a secondary listing on Nasdaq on Dec 31, 2021. At the time, the group said the potential listing and placement of new shares in ...

Medicus Pharma Ltd (NASDAQ:MDCX) is one of the Canadian penny stocks to buy right now. On November 18, Maxim Group analyst ...

On September 8, 2025, Nasdaq submitted a first-of-its-kind application to the Securities and Exchange Commission (SEC) to amend Nasdaq rules to ...

Qure N.V. (NASDAQ:QURE) ranks among the most oversold biotech stocks to invest in. William Blair reaffirmed its Market Perform rating for uniQure N.V.

SciSparc Ltd. (Nasdaq: SPRC) ('Company” or 'SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ('NeuroThera') ...

Austin, Texas, United States, November 13th, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage ...